МОРФОЛОГИЧЕСКИЕ КРИТЕРИИ АГРЕССИВНОСТИ ФИЛОИДНЫХ ОПУХОЛЕЙ МОЛОЧНОЙ ЖЕЛЕЗЫ В КОНТЕКСТЕ ПРОГНОЗИРОВАНИЯ КЛИНИЧЕСКОГО ИСХОДА
Ключевые слова:
филоидные опухоли, морфология, агрессивность, Ki-67, прогноз, митозы, гиперклеточность, иммуногистохимия.Аннотация
В обзорной статье проанализированы морфологические и иммуногистохимические критерии агрессивности филоидных опухолей молочной железы. Рассмотрены ключевые параметры (атипия, митозы, гиперклеточность, Ki-67, p53) и их связь с прогнозом. Выявлены различия во взглядах авторов и подчёркнута необходимость стандартизации диагностики и прогностических подходов.
Библиографические ссылки
Globocan. Global Cancer Observatory – International Agency for Research on Cancer. 2022
Ilchenko A.V., Stepanov V.A., Lomakina N.V. Phyllodes tumors of the breast: clinicomorphological characteristics and therapeutic approaches. Oncology. P.A. Hertzen Journal, No. 1, 2020, pp. 45–50.
Jara-Lazaro, A. R., Tan, P. H. Predicting clinical behaviour in phyllodes tumours. Pathology, 2020, 52(1), 32–38.
Karim, R. Z., Gerega, S. K., Yang, Y. H., et al. Margin status impact on recurrence of phyllodes tumors in high-risk groups. BMC Cancer, 2023, 23(1), 105.
Kumarguru, B. N., Rajalakshmi, T., & Lakshmikantha, M. Histopathological study of phyllodes tumor of breast: An institutional experience. Indian Journal of Pathology and Microbiology, 2021, 64(1), 57–61.
Limaiem, F., & Kashyap, S. Phyllodes Tumor of the Breast. In StatPearls. StatPearls Publishing. 2023
Macdonald, O. K., Lee, C. M., Tward, J. D., et al. Malignant phyllodes tumor of the female breast: association of primary therapy with cause-specific survival from the Surveillance, Epidemiology, and End Results (SEER) program. Cancer, 2006, 107(9), 2127–2133.
Ni, Y., & Tse, G. M. Spindle Cell Lesions of the Breast: A Diagnostic Algorithm. Archives of Pathology & Laboratory Medicine, 2023, 147(1), 30–37.
Sung, H., Ferlay, J., Siegel, R. L., Laversanne, M., Soerjomataram, I., Jemal, A., & Bray, F. Global Cancer Statistics 2020: GLOBOCAN Estimates of Incidence and Mortality Worldwide for 36 Cancers in 185 Countries. CA: A Cancer Journal for Clinicians, 2021, 71(3), 209–249.
Tan, B. Y., Fox, S. B., Lakhani, S. R., & Tan, P. H. Survey of recurrent diagnostic challenges in breast phyllodes tumours. Histopathology, 2023, 82(1), 95–105.
Tan, P. H., & Ellis, I. O. Atypia in breast pathology: what pathologists need to know. Pathology, 2021, 53(7), 835–847.
Tan, P. H., & Thike, A. A. Fibroepithelial tumours of the breast-a review. Virchows Archiv, 2021, 479(1), 1–14.
Tan, P. H., Jayabaskar, T., Chuah, K. L., Lee, H. Y., Tan, Y., Hilmy, M., Selvarajan, S., & Bay, B. H. Phyllodes tumours of the breast: a consensus review. Histopathology, 2005. 68(1), 5–21.
Tan PH, Thike AA, Tan WJ, et al. Predicting clinical behaviour of breast phyllodes tumours: a nomogram based on histological criteria and surgical margins. J Clin Pathol. 2012; 65:69–76.
Tsang JYS, Ni Y-B, Ng EK, et al. MicroRNAs are differentially deregulated in mammary malignant phyllodes tumour. Histopathology. 2015; 67:294–305.
Tse, G. M. Phyllodes tumors of the breast: an update. Breast Cancer, 2019, 26(3), 251–256.
WHO Classification of Tumours Editorial Board. Breast Tumours. WHO Classification of Tumours, 5th ed., vol. 2. Lyon: IARC. 2022
